We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Researchers Anxious for FDA to Launch Enhanced AERS
Drug Researchers Anxious for FDA to Launch Enhanced AERS
April 8, 2005
Clinical trials professionals hope the FDA will have a new adverse event reporting system (AERS) in place before the end of next year to help streamline the reporting process, which has become increasingly onerous for researchers.